During a White House meeting with Irish Taoiseach Micheál Martin, Trump accused Ireland of stealing US pharmaceutical companies and their associated tax revenue ...

In this week's SBJ Marketing newsletter, Terry Lefton looks at date behind big brands putting even bigger dollars into ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Ignore the noise in GLP-1 stocks. Find the best value instead.

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker ...

Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, ...

Roche acquired rights to an obesity therapy by Danish biotech firm Zealand Pharma in a collaboration deal worth up to $5.3 ...

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

The health regulator announced last month that there was no longer a shortage of Novo's Wegovy and diabetes drug Ozempic, both known chemically as semaglutide, and gave compounding pharmacies 60 to 90 ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Indiana University Health is building a new hospital on a 44-acre campus in Indianapolis. The facility will consolidate the ...